These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 32164051)

  • 1. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
    Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
    Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study.
    Xu Y; Chen X; Zhang M; Xiao Y; Zong J; Guo Q; Qiu S; Zheng W; Lin S; Pan J
    Cancer Med; 2017 Oct; 6(10):2213-2221. PubMed ID: 28879654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
    Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
    Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
    Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
    Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    Zhang Y; Li WF; Chen L; Mao YP; Guo R; Zhang F; Peng H; Liu LZ; Li L; Liu Q; Ma J
    Sci Rep; 2015 Sep; 5():13919. PubMed ID: 26345410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis of nasopharyngeal carcinoma to parotid lymph nodes: a retrospective study.
    Wang S; Lou J; Zhang S; Guo L; Wang K; Ge M
    World J Surg Oncol; 2015 Jan; 13():1. PubMed ID: 25622525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
    Yao JJ; Lin L; Gao TS; Zhang WJ; Lawrence WR; Ma J; Sun Y
    Cancer Res Treat; 2021 Jul; 53(3):657-670. PubMed ID: 33285052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Prognostic Nomogram Based on Residual Tumor in Patients With Nondisseminated Nasopharyngeal Carcinoma.
    Liao PY; Dong ZY; Huang CT; Tang XR; Liu GD; Zhu-Liu ; Wu DH
    Technol Cancer Res Treat; 2020; 19():1533033820957035. PubMed ID: 32945239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Li W; Lu H; Wang H; Hu L; Sun X; Yu H; Wang D
    Head Neck; 2021 Aug; 43(8):2353-2363. PubMed ID: 33780078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
    Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases.
    Ma J; Zhao R; Wu YL; Liu Y; Jin GQ; Su DK
    Cancer Imaging; 2023 Dec; 23(1):123. PubMed ID: 38102725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery.
    Li W; Lu H; Liu J; Liu Q; Wang H; Zhang H; Hu L; Zhao W; Gu Y; Li H; Sun X; Wang D
    Oral Oncol; 2020 Dec; 111():104922. PubMed ID: 32712576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nomograms for nasopharyngeal carcinoma with nodal features and potential indication for N staging system: Validation and comparison of seven N stage schemes.
    Peng WS; Xing X; Li YJ; Ding JH; Mo M; Xu TT; Zhou X; Hu CS
    Oral Oncol; 2023 Sep; 144():106438. PubMed ID: 37437499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure in patients with nasopharyngeal cancer of Northeastern region of India: a retrospective observational study.
    Bhattacharyya M; Medhi PP; Sharma P; Nath J; Kalita AK; Roy PS; Rahman T; Yanthan Y
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3743-3753. PubMed ID: 38578506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
    Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
    Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.
    Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L
    Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.